|
|
![]() |
|||||||||
|
Vol. 3
April
29, 2005 |
||||||||||
|
||||||||||
| Update on NT
Pro-BNP A study of 1034 patients undergoing angiography for symptoms of CAD and followed for a median of 9.2 years found that elevated Pro-BNP was the strongest predictor of death in a multivariate model (N Engl J Med 2005; 352:666-675). Having a Pro-BNP in the highest quartile conferred a hazard ratio of dying of 2.4 (95% CI 1.5-4.0). As a comparison having severe versus no coronary artery disease carried a hazard ratio of 1.8 (95% CI 1.2-2.6) in the same multivariate model. Another study of 764 participants aged 50-89 showed an increased risk of mortality and first coronary event associated with an elevation of NT Pro-BNP above the 80th percentile (JAMA. 2005;293:1609-1616). During 5 years of follow-up and after adjustment for other cardiovascular risk factors, the hazard ratio (HR) of death associated with an elevation of NT Pro-BNP as described was 1.96 (95% CI 1.21-3.19). Elevation of NT Pro-BNP levels were associated with first major cardiovascular events (nonfatal myocardial infarction, fatal coronary heart disease, unstable angina, heart failure, stroke, and transient ischemic attack) with an adjusted HR of 3.24 (95% CI, 1.80-5.79). NT Pro-BNP was found to be the strongest independent predictor of a diagnosis of Congestive Heart Failure in a group of 600 patients presenting to the emergency Room with a complaint of shortness of breath (Am J Cardiol 2005;95:948-954). Pro-BNP cutpoints of > 450 pg/ml in those < 50 years of age and > 900 pg/ml in those > 49 years of age were found to be highly sensitive and specific for acute congestive heart failure.
For many years, LabOne's Insurance Services Group has worked to vertically integrate laboratory testing with other insurance requirement acquisition products. To aid in our ability to communicate the unique benefits of our comprehensive solutions and value-added services such as CaseOne, we will phase out the Intellisys name and logo during the second and third quarters of 2005. The below chart illustrates the new product organization.
This change will not affect the comprehensive product line currently offered to insurance underwriters, agents and brokers, although several products will be sold as LabOne or ExamOne instead of Intellisys. If you have any questions, please contact your LabOne Regional Vice President.
Members of LabOne's new Client Advisory Group were surveyed recently to obtain feedback on areas of interest pertaining to the group's activities. In addition, members completed a focused questionnaire to provide direction on what type of content they would find most useful when utilizing LabOne's web site. With regard to group topics, over ninety percent of members were most interested in innovation in the industry coupled with new idea generation, and the examination of requirement gathering processes and related workflow. Members also provided specific feedback with regard to desired web site content referencing topics that will enable them to meet their information needs. The group's input is already hard at work within LabOne. Web site functionality and content is being developed according to the guidance provided by members. We would like to thank the group and express our appreciation for their time and effort. If you are interested in joining the group, please contact Dianne Schuetz at dianne.schuetz@labone.com.
LabOne Live Facts LabOne Live provides statistical information through the web 24 hours a day, 7 days a week. Many LabOne customers have been accessing this tool since March 2003. However, did you know about the following features LabOne Live offers?
For more information or to register for LabOne Live, please email sasmanager@labone.com.
Effective June 1, 2005, South Carolina's state fee for MVRs will change from $6.00 to $7.25. Please share this information with your Accounts Payable team to facilitate their bill reconcilements.
Two features of CaseOne are highlighted below:
A clear advantage of CaseOne: Improved resource allocation at the Home Office level!
Did you know that you could do the following in CaseView:
If you need any assistance please contact our Client Technical Support department at 800 388-4675.
Richard Braun, M.D., LabOne Medical Director and Senior Vice President, will present at the following meetings: May 6 - Midwest Medical Directors Association Dr. Braun is also presenting to numerous insurance companies in the coming months. Industry Meetings Come see ExamOne at: Senior Market Expo NAILBA FOCUS June 5-8 in Reno, NV. MDRT
|
||||||||||
| |
||||||||||
| ©
2005 LabOne, Inc. | All Rights Reserved.
| www.LabOne.com |
||||||||||
| Want
to be removed? If you do not wish to receive this newsletter, please email
jody.tomlinson@LabOne.com.
You can also give us the email address of others within your organization
that would like to receive this newsletter. Thank you! |
||||||||||